The Million Hearts initiative, which aims to prevent a million cardiovascular events in a 5-year period, will focus on utilizing its partnerships with health systems and employers as it embarks upon its second phase, according to Janet Wright, MD, FACC, the program’s executive director.
The Million Hearts initiative, which aims to prevent a million cardiovascular events in a 5-year period, will focus on utilizing its partnerships with health systems and employers as it embarks upon its second phase, according to Janet Wright, MD, FACC, the program’s executive director.
Transcript (slightly modified)
What’s on the horizon for the Million Hearts initiative in the coming years?
What we’re excited about in Million Hearts 2022 is first and foremost that all of the partnerships and relationships that were either formed or deepened in the first 5 years are geared up and ready to go. In fact, their wheels are all turning. So we believe that although we likely will not have prevented a million events in the first 5 years, we are setting that aim again for the second 5 years, and we believe that the partnerships and many different types of relationships are the ticket to getting there.
In addition, there are some policies that started out in late 2011 and early 2012 that were conceptual, but now are actually pervasive across the country. So more and more places are basing their payment on value, and that allows performance of a whole team of people, really getting away from the fee-for-service model. And in addition, we have a number of best practices and lessons learned that we can layer on top of the existing evidence to make sure that improvements occur quickly.
Frankly, all 50 states have been involved in Million Hearts, including the District of Columbia, as well as many health systems. We will be looking to hospitals and academic medical centers as major partners in 2022, as well as employers who care deeply about the health of their employees.
Standard Criteria for Loss of Ambulation Needed in DMD
April 19th 2024A recent study suggests the differences between ambulation definitions for patients with Duchenne muscular dystrophy (DMD) can impact the identification of ambulant vs nonambulant individuals, and standard criteria across settings are needed.
Read More
The Importance of Examining and Preventing Atrial Fibrillation
August 29th 2023At this year’s American Society for Preventive Cardiology Congress on CVD Prevention, Emelia J. Benjamin, MD, ScM, delivered the Honorary Fellow Award Lecture, “The Imperative to Focus on the Prevention of Atrial Fibrillation,” as the recipient of this year’s Honorary Fellow of the American Society for Preventive Cardiology award.
Listen
An Overview of Health Care and Pharmaceutical Trends, 2023-2024
April 19th 2024Douglas M. Long, BA, MBA, was featured as the keynote speaker on the closing day of The Academy of Managed Care Pharmacy 2024 annual meeting, with a session dedicated to surveying the health care and pharmaceutical trends of the last year.
Read More
Promoting Equity in Public Health: Policy, Investment, and Community Engagement Solutions
June 28th 2022On this episode of Managed Care Cast, we speak with Georges C. Benjamin, MD, executive director of the American Public Health Association, on the core takeaways of his keynote session at AHIP 2022 on public health policy and other solutions to promote equitable health and well-being.
Listen
Collecting SDOH Data Can Assess Risk of Medical Nonadherence, Improve HEI and Star Ratings
April 18th 2024At the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting, a panel of presenters explored changes coming to Medicare that incorporate social determinants of health (SDOH) data to improve patient and health system outcomes.
Read More